Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerAvandia?s Positive Response Fueled by Glaxo
By Jamie Sheller
The New York Times published an article recently about the positive reviews that GlaxoSmithKline's diabetes drug, Avandia, has received in articles written by experts. An analysis of hundreds of articles dating from 2007 showed that more often than not, experts who were paid by GlaxoSmithKline, had positive reviews about the drug.
According to a March 18, 2010 article published in the British Medical Journal, researchers reviewed over 200 articles written by 180 authors about the relationship between Avandia and heart attacks. The research showed that of the favorable opinions, 87 percent of authors had some type of conflict of interest with GlaxoSmithKline. Only 20 percent of those with unfavorable opinions of Avandia had financial ties to Glaxo.
In 2007, the New England Journal of Medicine published studies that showed the use of Avandia was associated with an increased risk of having a heart attack. Confidential FDA reports, described by the New York Times in February, detailed their recommendation that Avandia should be removed from the market.
Sheller, P.C. is a national law firm handling defective drug cases. If you or someone you know has had a heart attack or stroke as a result of taking Avandia, please contact Sheller, P.C.
Originally posted at InjuryBoard by Jamie ShellerFull post as published by Philadelphia Personal Injury Lawyer on April 13, 2010 (boomark / email).
Glaxo Defends Handling of Avandia Heart Risks
GlaxoSmithKline said this week that a Senate report criticizing its handling of heart risks with its diabetes drug Avandia "mischaracterizes and distorts" the company's record. As reported by the Associated Press, Glaxo is unhappy with the way the company's response...
Avandia Heart Attack: Questions Still Remain
Washington, DC: The Avandia debacle continues to daze and confuse in the face of conflicting information. GlaxoSmithKline (Glaxo), the makers of Avandia, continue to claim that studies conclude there is no risk of Avandia heart attack...
Don't Cry for Avandia Maker Glaxo Just Yet
Philadelphia, PA: Profits may have been down in the first quarter when compared to a year ago, but the manufacturer of Avandia and gatekeeper of the Avandia recall appears to be holding its own...
Avandia Decline Not Affecting GlaxoSmithKline
Philadelphia, PA: While profits may have been down in the first quarter when compared to a year ago, Avandia manufacturer GlaxoSmithKline (Glaxo) appears to be doing well. And while the risk for Avandia heart attack and other Avandia side effects continues for Type 2 diabetes patients-and critics continue to lobby for an Avandia recall-Glaxo's own health appears to be stable, if not robust.
New Study Suggests Avandia Worse than Actos, Glaxo Cries Foul
Toronto, ON: New research out of Canada pertaining to Avandia side effects and Avandia risks appears to suggest that patients taking Avandia have a greater chance for developing heart failure?and have a greater risk of death?than those taking rival type 2 diabetes drug Actos.
Fed Report Shows Diabetes Drug Avandia Can Kill You
Recent reports by Dr. David Graham and Dr. Kate Gelperin show that GlaxoSmithKline's diabetes drug Avandia should be pulled from the market. The reason? It can kill you!This comes as no surprise to many of us who have been filing cases against GlaxoSmithKline...
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
Avandia
alleging heart attacks, increased fracture risk that may have been caused by Avandia.









